Skip to content


You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Dermatology

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial

  • Kim A. Papp1,
  • Robert Bissonnette2,
  • Melinda Gooderham3,
  • Steven R. Feldman4,
  • Lars Iversen5,
  • Jennifer Soung6,
  • Zoe Draelos7,
  • Carla Mamolo8,
  • Vivek Purohit8,
  • Cunshan Wang8 and
  • William C. Ports8Email author
BMC DermatologyBMC series – open, inclusive and trusted201616:15

Received: 3 April 2016

Accepted: 9 September 2016

Published: 3 October 2016

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting

Original Submission
3 Apr 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
9 Sep 2016 Editorially accepted
3 Oct 2016 Article published 10.1186/s12895-016-0051-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

K Papp Clinical Research and Probity Medical Research Inc
Innovaderm Research
SKiN Centre for Dermatology and Probity Medical Research Inc, Peterborough, and Queens University
Wake Forest Baptist Health
Aarhus University Hospital
Southern California Dermatology
Dermatology Consulting Services
Pfizer Worldwide Biopharmaceuticals, Global Innovative Pharma Business